Non-Hodgkin Lymphoma

This research could potentially pave the way for possible immunotherapy approaches for common forms of non-Hodgkin lymphoma.

Research on chimeric antigen receptor T-cell therapy to be presented at the ASH Annual Meeting & Exposition is set to address drawbacks associated with treatment.

After conflicting opinions over the years, a study published in the journal Hematology explores the association between diabetes mellitus non-hodgkin lymphoma.